Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Revive Therapeutics Ltd. RVVTF

Set alert

Price alert · RVVTF

All alert types
0.01 USD 0.00 -6.67%

At close · Oct 30

0.014 Day range 0.0146
0.007 52-week range 0.052
YTD
+75.00%
1 year
+40.00%
Open
0.0146
Prev close
0.015
Mkt cap
6.10M
Vol
82.50K
Avg vol
167.01K
EPS
-0.02
P/E
0.00
More statistics
Low
0.014
High
0.0146

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for RVVTF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-528.49 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.7×
FY 2016: -0.9×FY 2017: -6.3×FY 2018: -6.2×FY 2019: -5.2×FY 2020: -5.7×FY 2021: -7.7×FY 2022: -8.1×FY 2023: -2.7×FY 2024: -0.6×FY 2025: -0.7×
FY 2016 5y median -2.7× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -2.4×
FY 2016: 4.4×FY 2017: 6.3×FY 2018: 13.6×FY 2019: 7.3×FY 2020: 4.1×FY 2021: 5.4×FY 2022: 11.4×FY 2023: 1.6×FY 2024: 0.5×FY 2025: -2.4×
FY 2016 5y median 1.6× FY 2025
P/FCF -10.8×
FY 2016: -1.3×FY 2017: -4.9×FY 2018: -7.4×FY 2019: -5.9×FY 2020: -12.2×FY 2021: -13.8×FY 2022: -11.0×FY 2023: -2.9×FY 2024: -1.0×FY 2025: -10.8×
FY 2016 5y median -10.8× FY 2025
EV/EBITDA -0.8×
FY 2016: -0.4×FY 2017: -5.0×FY 2018: -5.5×FY 2019: -5.0×FY 2020: -8.2×FY 2021: -7.5×FY 2022: -7.9×FY 2023: -2.8×FY 2024: -0.8×FY 2025: -0.8×
FY 2016 5y median -2.8× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -9.3%
FY 2016: -79.3%FY 2017: -20.4%FY 2018: -13.5%FY 2019: -16.9%FY 2020: -8.2%FY 2021: -7.3%FY 2022: -9.1%FY 2023: -35.0%FY 2024: -95.8%FY 2025: -9.3%
FY 2016 5y median -9.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 318.6%
FY 2016: -481.5%FY 2017: -100.0%FY 2018: -218.1%FY 2019: -139.9%FY 2020: -72.4%FY 2021: -69.8%FY 2022: -141.3%FY 2023: -59.3%FY 2024: -77.7%FY 2025: 318.6%
FY 2016 5y median -69.8% FY 2025
ROIC 49.8%
FY 2016: -474.4%FY 2017: -103.7%FY 2018: -224.0%FY 2019: -136.7%FY 2020: -46.0%FY 2021: -63.4%FY 2022: -137.2%FY 2023: -50.5%FY 2024: -44.8%FY 2025: 49.8%
FY 2016 5y median -50.5% FY 2025
ROA -5370.8%
FY 2016: -197.4%FY 2017: -84.0%FY 2018: -159.8%FY 2019: -104.8%FY 2020: -65.1%FY 2021: -67.5%FY 2022: -104.3%FY 2023: -44.4%FY 2024: -52.8%FY 2025: -5370.8%
FY 2016 5y median -67.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 49.9%
FY 2016: -34.3%FY 2017: 37.9%FY 2018: -9.8%FY 2019: 28.6%FY 2020: -178.5%FY 2021: -407.8%FY 2022: 3.9%FY 2023: 69.0%FY 2024: 40.5%FY 2025: 49.9%
FY 2016 FY 2025
EPS (diluted) -102.7%
FY 2016: -16.8%FY 2017: 69.2%FY 2018: 5.3%FY 2019: 34.6%FY 2020: -140.0%FY 2021: -49.2%FY 2022: 25.9%FY 2023: 66.6%FY 2024: 20.4%FY 2025: -102.7%
FY 2016 FY 2025
Free Cash Flow 76.7%
FY 2016: -29.8%FY 2017: -4.8%FY 2018: 27.5%FY 2019: 21.4%FY 2020: -112.2%FY 2021: -349.5%FY 2022: -15.5%FY 2023: 53.9%FY 2024: 45.4%FY 2025: 76.7%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 1.6×FY 2017: 6.2×FY 2018: 3.6×FY 2019: 1.6×FY 2020: 5.8×FY 2021: 28.1×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 0.3×FY 2025: 0.0×
FY 2016 5y median 0.7× FY 2025
Quick Ratio 0.0×
FY 2016: 1.6×FY 2017: 6.2×FY 2018: 3.6×FY 2019: 1.6×FY 2020: 5.8×FY 2021: 28.1×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 0.3×FY 2025: 0.0×
FY 2016 5y median 0.7× FY 2025
Debt / Equity -0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 0.5×FY 2017: 1.1×FY 2018: 0.6×FY 2019: 0.4×FY 2020: 0.3×FY 2021: 0.9×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.2×FY 2025: -0.0×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -2609×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -676×FY 2019: -517×FY 2020: -41.7×FY 2021: -235×FY 2022: -281×FY 2023: -126×FY 2024: -164×FY 2025: -2609×
FY 2016 5y median -235× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-06-30